In contrast to its tumor-suppressive activity, SYVN1 exerts tumor-promoting effects through ubiquitination and degradation of tumor-suppressors in different cancers, including colon cancer [11], prostate cancer [3], lung cancer [2], and hepatocellular carcinoma [8]. This evidence concerns the gene SYVN1 and prostate carcinoma.